iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 2,575.00
+25.00 (0.98%)
Jul 1, 2026, 9:28 AM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 80.62 billion as of June 30, 2026. Its market cap has decreased by -40.84% in one year.
Market Cap
80.62B
Enterprise Value
42.19B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,575.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 80.62B, a decrease of -15.41%. That is a compound annual growth rate of -1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 80.62B | -21.54% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 133.24B |
| NeoImmuneTech | 130.80B |
| Genexine | 120.52B |
| Vaxcell-Bio Therapeutics | 119.54B |
| MedPacto | 107.80B |
| Amicogen | 104.34B |
| ENCell | 84.82B |
| Prestige BioPharma | 77.64B |